BIOJECT MEDICAL TECHNOLOGIES INC
10-K405, EX-10.37, 2000-06-29
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Previous: BIOJECT MEDICAL TECHNOLOGIES INC, 10-K405, EX-10.36, 2000-06-29
Next: BIOJECT MEDICAL TECHNOLOGIES INC, 10-K405, EX-23, 2000-06-29

EXHIBIT 10.37

REGISTRATION RIGHTS AGREEMENT

    This Agreement is made as of December 1, 1999 by and among BIOJECT MEDICAL TECHNOLOGIES INC., an Oregon corporation (the "Corporation"), and Frederick R. Pierce, II ("Rick Pierce").

RECITALS

    Simultaneously herewith, the Corporation has issued a Series "R" Common Stock Purchase Warrant to Rick Pierce to purchase up to an aggregate of 4,000 shares of the Corporation's Common Stock (the "Warrants").

AGREEMENT

    NOW, THEREFORE, it is hereby agreed as follows:

1.  Certain Definitions

    As used in this Agreement, the following terms shall have the following respective meanings:

    "Common Stock" shall mean shares of common stock, without par value, of the Corporation.

    "Commission" shall mean the Securities and Exchange Commission.

    "Holder" shall mean the holders of Registrable Securities and any person holding such securities to whom the rights under this Agreement have been transferred in accordance with Section 2.8 hereof.

    "Initiating Holders" shall mean any Holder or Holders of the Registrable Securities initiating a registration request pursuant to Sections 2.2(b) and 2.2(c).

    "Registrable Securities" means (i) all shares of the Corporation's Common Stock acquired upon exercise of the Series "R" Warrants (the "Shares"), and (ii) any Common Stock or other securities of the Corporation issued or issuable with respect to, or in exchange for or in replacement of the Shares or such additional shares upon any stock split, stock dividend, recapitalization, or similar event; provided, however, that shares of Common Stock or other securities shall only be treated as Registrable Securities for the purposes of Section 2 hereof if and so long as they have not been sold pursuant to Rule 144 under the Securities Act or pursuant to an effective Registration Statement under the Securities Act, or otherwise to or through a broker or dealer or underwriter in a public distribution or a public securities transaction.

    The terms "register," "registered" and "registration" refer to a registration effected by preparing and filing a registration statement in compliance with the Securities Act, and the declaration or ordering of the effectiveness of such registration statement.

    "Registration Expenses" shall mean all expenses, except as otherwise stated below, incurred by the Corporation in complying with Section 2 hereof, including, without limitation, all registration, qualification and filing fees, printing expenses, escrow fees, fees and disbursements of counsel for the Corporation and one special counsel to the selling Holders, blue sky fees and expenses, fees to Nasdaq to list the Shares or American Stock Transfer and Trust Company to issue the Shares, and the expense of any special audits incident to or required by any such registration.

    "Securities Act" shall mean the Securities Act of 1933, as amended, or any similar federal statute and the rules and regulations of the Commission thereunder, all as the same shall be in effect at the time.

    "Selling Expenses" shall mean all underwriting discounts, selling commissions and stock transfer taxes applicable to the securities registered by the selling Holders and any other expenses that are not Registration Expenses and that are incurred by the selling Holders.

1


2.  Registration Rights

    2.1  Company Registration  

    2.2  Demand Registration  

2


3


    2.3  Expenses of Registration  

    All Registration Expenses incurred in connection with registration pursuant to Sections 2.1 and 2.2 shall be borne by the Corporation. All Selling Expenses relating to securities registered on behalf of the Holders shall be borne by the Holders of securities included in such registration pro rata, severally and not jointly, among each other on the basis of the number of shares so registered.

    2.4  Registration Procedures  

    In the case of each registration effected by the Corporation pursuant to this Section 2, the Corporation will keep each Holder advised in writing as to the initiation of each registration and as to the completion thereof. At its expense the Corporation will:

    2.5  Indemnification  

4


5


    2.6  Information by Holder  

    The Holder or Holders of Registrable Securities included in any registration shall furnish to the Corporation such information regarding such Holder or Holders, the Registrable Securities held by them and the distribution proposed by such Holder or Holders as the Corporation may reasonably request in writing and as shall be required in connection with any registration, qualification or compliance referred to in this Section 2.

6


    2.7  Rule 144 Reporting  

    With a view to making available the benefits of certain rules and regulations of the Commission which may at any time permit the sale of the Registrable Securities to the public without registration, the Corporation agrees to use its best efforts to:

    2.8  Transfer of Registration Rights  

    The rights to cause the Corporation to register securities granted Holders under this Section 2 may be assigned (a) to a transferee or assignee in connection with any transfer or assignment of Registrable Securities by a Holder of not less than 20,000 shares of Registrable Securities (as presently constituted and subject to subsequent adjustments for stock splits, stock dividends, reverse stock splits, and the like), or (b) to the estate of a Holder, provided in each case that such transfer may otherwise be effected in accordance with applicable securities laws and written notice of the transfer is given to the Corporation at the time of or within a reasonable time after such transfer or assignment, stating the name and address of the transferee or assignee and identifying the Registrable Securities with respect to which such registration rights are being transferred or assigned, and provided, further, that the transferee or assignee of such rights agrees in writing to be bound by the terms of this Agreement as if such transferee were a party hereto.

    2.9  Standoff Agreement  

    Each Holder agrees, in connection with registered public offerings of the Corporation's securities for the account of the Corporation, upon request of the Corporation or the underwriters managing any underwritten offering of the Corporation's securities, not to sell, make any short sale of or otherwise dispose of any Registrable Securities (other than those included in the registration) without the prior written consent of the Corporation or such underwriters, as the case may be, for such period of time (not to exceed 120 days in the case of other public offerings) from the effective date of such registration as may be requested by the underwriters, provided, that the officers and directors of the Corporation who own stock of the Corporation also agree to such restrictions.

    2.10  Termination of Registration Rights  

    The rights granted under this Section 2 shall terminate on the earlier of December 1, 2000.

    2.11  Delay of Registration  

    No Holder or Holders shall have any right to take any action to restrain, enjoin, or otherwise delay any registration as a result of any controversy that might arise with respect to the interpretation or implementation of this Section 2.

7


    2.12  Use of Form S-3  

    With a view to maintaining its eligibility to use Form S-3, the Corporation agrees to use its best efforts to file with the Commission in a timely manner (i) all the material required to be filed pursuant to Sections 13, 14 or 15(d) of the Securities Exchange Act of 1934, as amended, and (ii) all reports and other documents required to be filed by the Corporation under the Securities Act and the Securities Exchange Act of 1934, as amended; provided, however, that there can be no assurance that the Corporation will remain eligible for use of Form S-3 or that any Form S-3 filed by the Corporation with respect to the Registrable Securities will be declared effective.

3.  Miscellaneous

    3.1  Waivers and Amendments  

    With the written consent of both the Corporation and Holders of a majority of outstanding Registrable Securities originally acquired by Rick Pierce then held by Holders (voting together as a class), the obligations of the Corporation and the rights of such Holders of Registrable Securities under this Agreement may be waived (either generally or in a particular instance, and either for a specified period of time or indefinitely), and with the same consent the Corporation, when authorized by resolution of its Board of Directors, may enter into a supplementary agreement for the purpose of adding any provisions to or changing in any manner or eliminating any of the provisions of this Agreement. Neither this Agreement nor any provisions hereof may be changed, waived, discharged or terminated orally, but only by a signed statement in writing.

    3.2  Governing Law  

    This Agreement shall be governed in all respects by the laws of the State of Oregon as such laws are applied to agreements between Oregon residents entered into and to be performed entirely within Oregon.

    3.3  Successors and Assigns  

    Except as otherwise expressly provided herein, the Provisions hereof shall inure to the benefit of, and be binding upon, the successors, assigns, heirs, executors and administrators of the parties hereto.

    3.4  Entire Agreement  

    This Agreement constitutes the full and entire understanding and agreement between the parties with regard to the subjects hereof.

    3.5  Notices  

    All notices and other communications required or permitted hereunder shall be effective upon receipt and shall be in writing and may be delivered in person, by telecopy, electronic mail, overnight delivery service or U.S. mail, in which event it may be mailed by first class, postage prepaid, addressed (a) if to Rick Pierce, at the address set forth on the signature page hereto, or at such other address as the Holder shall have furnished to the Corporation, or (b) if to the Corporation, at 7620 SW Bridgeport Road, Portland, Oregon 97224, Attention: President, or at such other address as shall have furnished to the Holders in writing. Notwithstanding the foregoing, all notices and communications to addresses outside the United States shall be given by telecopier and confirmed in writing sent by overnight or two-day courier service.

    3.6  Titles and Subtitles  

    The titles of the paragraphs and subparagraphs of this Agreement are for convenience of reference only and are not to be considered in construing this Agreement.

8


    3.7  Litigation; Prevailing Party  

    In the event of any litigation between the Corporation and Rick Pierce with regard to this Agreement, the prevailing party shall be entitled to reimbursement from the nonprevailing party for all reasonable fees and expenses of counsel for the prevailing party.

    3.8  Nominees  

    Securities registered in the name of a nominee for a Holder shall, for purposes of this Agreement, be treated as being owned by such Holder.

    3.9  Counterparts  

    This Agreement may be executed in any number of counterparts, each of which shall be an original, but all of which together shall constitute one instrument. Delivery of a signed counterpart by and between telephone facsimile transmission shall between effective as delivery of a manually signed counterpart of this Agreement.

    IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the date set forth above.

    BIOJECT MEDICAL TECHNOLOGIES INC.
 
 
 
 
 
By:
 
 
     
    Name: Christine M. Farrell
Title: Controller & Secretary
 
 
 
 
 
Frederick R. Pierce, II
 
 
 
 
 
 
 
 

Signature
 
 
 
 
 
 
 
 

Print Name
 
 
 
 
 
 
 
 

Print Title
 
 
 
 
 
 
 
 

 
 
 
 
 
 
 
 

Address
 
 
 
 
 
 
 
 
 
 
 
 

9





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission